Results 1 to 10 of about 1,171,841 (304)

A simple, single-tube overlapping amplicon-targeted Illumina sequencing assay. [PDF]

open access: yesPLoS ONE, 2023
Targeted amplicon sequencing to identify pathogens, resistance-conferring mutations, and strain types is an important tool in diagnosing and treating infections. However, due to the short read limitations of Illumina sequencing, many applications require
Jason D Limberis   +3 more
doaj   +6 more sources

Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens. [PDF]

open access: yesJournal of Clinical Microbiology
Whole-genome sequencing has become the method of choice for bacterial outbreak investigation, with most clinical and public health laboratories currently routinely using short-read Illumina sequencing.
Bert Bogaerts, Kevin Vanneste
exaly   +3 more sources

From reads to results: comparing Oxford Nanopore to Illumina sequencing for citrus virus surveillance [PDF]

open access: yesBMC Genomics
Background ONT sequencing has been previously evaluated for its ability to detect plant viruses and viroids. Its advantages, such as longer read lengths and real-time analysis, compete with extensively validated Illumina platforms for possible ...
Madelein Dippenaar   +2 more
doaj   +2 more sources

Direct comparison of clear DX Nanopore and Illumina sequencing of SARS-CoV-2 [PDF]

open access: yesMicrobiology Spectrum
There are limited data directly comparing SARS-CoV-2 sequencing methods using two major commercial approaches, Oxford Nanopore Technologies Clear DX (ONTDX) and Illumina.
Wesley Hottel   +13 more
doaj   +2 more sources

Systematic Comparison of Nanopore and Illumina Sequencing for the Detection of Plant Viruses and Viroids Using Total RNA Sequencing Approach [PDF]

open access: yesFrontiers in Microbiology, 2022
High-throughput sequencing (HTS) has become an important tool for plant virus detection and discovery. Nanopore sequencing has been rapidly developing in the recent years and offers new possibilities for fast diagnostic applications of HTS.
Anja Pecman   +7 more
doaj   +2 more sources

Breaking the Standard: Can Oxford Nanopore Technologies Sequencing Compete With Illumina in Protistan Amplicon Studies?

open access: yesEnvironmental DNA
Advancements in sequencing technologies have revolutionized environmental research, leading to a superior understanding of ecosystem functions. In recent years, high‐throughput sequencing techniques evolved from short‐read Illumina sequencing to long ...
Jens Boenigk, Manan Shah, Aman Deep
exaly   +2 more sources

Viral Metagenomics: Analysis of Begomoviruses by Illumina High-Throughput Sequencing

open access: yesViruses, 2014
Traditional DNA sequencing methods are inefficient, lack the ability to discern the least abundant viral sequences, and ineffective for determining the extent of variability in viral populations. Here, populations of single-stranded DNA plant begomoviral
Shahjahan Ali   +2 more
exaly   +3 more sources

Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies

open access: yesGenome Biology, 2022
Background The cancer genome is commonly altered with thousands of structural rearrangements including insertions, deletions, translocation, inversions, duplications, and copy number variations.
Keyur Talsania   +38 more
doaj   +1 more source

Best practices for the interpretation and reporting of clinical whole genome sequencing

open access: yesnpj Genomic Medicine, 2022
Whole genome sequencing (WGS) shows promise as a first-tier diagnostic test for patients with rare genetic disorders. However, standards addressing the definition and deployment practice of a best-in-class test are lacking.
Christina A. Austin-Tse   +23 more
doaj   +1 more source

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy. [PDF]

open access: yesPLoS ONE, 2014
The impact of raltegravir-resistant HIV-1 minority variants (MVs) on raltegravir treatment failure is unknown. Illumina sequencing offers greater throughput than 454, but sequence analysis tools for viral sequencing are needed.
Jonathan Z Li   +30 more
doaj   +1 more source

Home - About - Disclaimer - Privacy